ATE238339T1 - Verbindungen zur regulierung der meiose - Google Patents

Verbindungen zur regulierung der meiose

Info

Publication number
ATE238339T1
ATE238339T1 AT97948753T AT97948753T ATE238339T1 AT E238339 T1 ATE238339 T1 AT E238339T1 AT 97948753 T AT97948753 T AT 97948753T AT 97948753 T AT97948753 T AT 97948753T AT E238339 T1 ATE238339 T1 AT E238339T1
Authority
AT
Austria
Prior art keywords
compounds
meiosis
useful
compounds regulating
regulating meiosis
Prior art date
Application number
AT97948753T
Other languages
English (en)
Inventor
Christian Grondahl
Frederik Christian Gronvald
Peter Faarup
Anthony Murray
Jan Lund Ottesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE238339T1 publication Critical patent/ATE238339T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Induction Heating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT97948753T 1996-12-20 1997-12-19 Verbindungen zur regulierung der meiose ATE238339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK147896 1996-12-20
US4148897P 1997-02-11 1997-02-11
PCT/DK1997/000584 WO1998028323A1 (en) 1996-12-20 1997-12-19 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
ATE238339T1 true ATE238339T1 (de) 2003-05-15

Family

ID=26065809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948753T ATE238339T1 (de) 1996-12-20 1997-12-19 Verbindungen zur regulierung der meiose

Country Status (12)

Country Link
US (3) US6486145B2 (de)
EP (1) EP0946584B1 (de)
JP (1) JP2001506656A (de)
KR (1) KR20000069616A (de)
AT (1) ATE238339T1 (de)
AU (1) AU746878B2 (de)
CA (1) CA2275683A1 (de)
DE (1) DE69721304T2 (de)
HU (1) HUP9904616A3 (de)
IL (1) IL130249A0 (de)
NO (1) NO313144B1 (de)
WO (1) WO1998028323A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030004148A1 (en) * 1994-06-23 2003-01-02 Byskov Anne G. Regulation of meiosis
JP2003522728A (ja) * 1998-05-13 2003-07-29 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
US6528501B1 (en) 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
KR20010101820A (ko) * 1999-02-10 2001-11-14 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
AU2794100A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
EP1156821B1 (de) 1999-02-24 2007-05-02 Novo Nordisk A/S Behandlung von unfruchtbarkeit
ATE392899T1 (de) 1999-03-02 2008-05-15 Organon Nv (androst-5-en-17beta-yl)alkyl sulfoxide und sulfone und deren verwendung zur kontrolle der fruchtbarkeit
DK1163258T3 (da) * 1999-03-09 2003-03-31 Akzo Nobel Nv Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
JP2003509365A (ja) 1999-09-16 2003-03-11 ノボ ノルディスク アクティーゼルスカブ Ivf用の組成物
EP1127890A1 (de) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid Derivate mit einem an Ring A des Steroidgerüstes kondensierten Ring zur Regulierung der Meiose
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
JP2003529378A (ja) * 2000-04-06 2003-10-07 ノボ ノルディスク アクティーゼルスカブ 卵母細胞の細胞質および核成熟の体外成熟方法
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
ATE386495T1 (de) * 2001-02-06 2008-03-15 Novo Nordisk As Behältnis mit niedrigem sauerstoffgehalt, das ff- mas enthält
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US8969543B2 (en) * 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US20080312673A1 (en) * 2007-06-05 2008-12-18 Viswanathan Raju R Method and apparatus for CTO crossing
EP3581563B1 (de) 2010-04-09 2023-06-28 The Research Foundation of the State University of New York Ship-inhibitor und verwendungen davon

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
DE1183079B (de) 1961-11-27 1964-12-10 Vismara Francesco Spa Verfahren zur Herstellung von gesaettigten 4-Hydroxy-3-keto-5alpha-steroiden
CH470374A (de) 1965-09-24 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von Steroiden
DE1593492A1 (de) 1966-01-29 1970-07-16 Schering Ag 6-Ketosteroide aus 20-Formyl-6-keto-Steroide
IL38540A0 (en) 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
ZA725157B (en) 1971-07-29 1973-04-25 Dauten Sa New steroid of insecticide action and process for its production
US4670190A (en) 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
NL7402846A (de) 1973-03-02 1974-09-04
IL41923A (en) 1973-04-01 1978-08-31 Yeda Res & Dev Preparation of hydroxylated derivatives of cholestanol and some such compounds
US3931403A (en) 1973-05-25 1976-01-06 Intellectual Property Development Corporation Antimicrobial compositions
US3887545A (en) 1973-11-12 1975-06-03 Hoffmann La Roche Synthesis of 1{60 -hydroxylated cholesterol derivatives
JPS5119752A (en) 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho
IL45897A (en) 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
JPS6039278B2 (ja) 1977-05-23 1985-09-05 中外製薬株式会社 ステロイド誘導体
CA1138859A (en) 1979-02-15 1983-01-04 Teijin Limited 25-hydroxy-24-oxocholestane derivatives and preparation thereof
US4230626A (en) 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4254045A (en) 1980-04-21 1981-03-03 Wisconsin Alumni Research Foundation 1α-Hydroxy-2β-fluorocholecalciferol
GB2089810B (en) 1980-09-22 1984-09-19 Wisconsin Alumni Res Found 23,25-dihydroxyvitamin d3 precursors
DE3265509D1 (en) 1981-04-29 1985-09-26 Hoffmann La Roche Process for the preparation of cholesterol derivatives, and intermediate derivatives therefor
US4329295A (en) 1981-06-29 1982-05-11 G. D. Searle & Co. 24-Cyclopropylcholene-3β, 22-diols and esters thereof
US4348328A (en) 1981-11-09 1982-09-07 G.D. Searle & Co. 25-Substituted-5α-cholestane-3β,22S-diol
US4871727A (en) 1987-12-21 1989-10-03 Merck & Co, Inc. Anti-inflammatory and antidegenerative compounds isolated from L-681,512
JPH0749435B2 (ja) 1988-07-04 1995-05-31 帝人株式会社 1α,3β,24−トリヒドロキシ−△▲上5▼−ステロイド類の製造方法
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
EP0813595A1 (de) * 1995-03-06 1997-12-29 Novo Nordisk A/S Anregung der meiose

Also Published As

Publication number Publication date
NO993009L (no) 1999-08-19
HUP9904616A3 (en) 2001-02-28
US6486145B2 (en) 2002-11-26
AU7878998A (en) 1998-07-17
CA2275683A1 (en) 1998-07-02
AU746878B2 (en) 2002-05-02
KR20000069616A (ko) 2000-11-25
WO1998028323A1 (en) 1998-07-02
EP0946584B1 (de) 2003-04-23
US6759400B2 (en) 2004-07-06
US20050004382A1 (en) 2005-01-06
DE69721304D1 (de) 2003-05-28
NO993009D0 (no) 1999-06-18
EP0946584A1 (de) 1999-10-06
US20010005757A1 (en) 2001-06-28
IL130249A0 (en) 2000-06-01
US20030032824A1 (en) 2003-02-13
DE69721304T2 (de) 2004-03-04
NO313144B1 (no) 2002-08-19
HUP9904616A2 (hu) 2000-06-28
JP2001506656A (ja) 2001-05-22

Similar Documents

Publication Publication Date Title
DE69721304D1 (de) Verbindungen zur Regulierung der Meiose
DE69429078D1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
MX9700174A (es) Derivados de esterol usados para la regulacion de la meiosis.
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
DK0799209T3 (da) Sulfonamider
NZ336042A (en) Farnesyl transferase inhibitors
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
DE59503178D1 (de) Verwendung von gelformulierungen als beizmittel
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
ATE256144T1 (de) Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
TR199901275T2 (xx) Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler.
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE177424T1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
ATE305785T1 (de) Cd45 hemmer
MX9800123A (es) Compuestos que regulan la meiosis.
DE59202744D1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties